Breaking News Instant updates and real-time market news.

PCTI

PCTEL

$4.63

-0.03 (-0.64%)

, RDWR

Radware

$24.79

0.38 (1.56%)

09:04
06/12/19
06/12
09:04
06/12/19
09:04

Three Part Advisors to hold a conference

East Coast IDEAS Investor Conference will be held in Boston on June 12-13 with webcasted company presentations to begin on June 12 at 8:30 am; not all company presentations may be webcasted. Webcast Link

PCTI

PCTEL

$4.63

-0.03 (-0.64%)

RDWR

Radware

$24.79

0.38 (1.56%)

UFPT

UFP Technologies

$39.43

-0.12 (-0.30%)

CWCO

Consolidated Water

$13.67

(0.00%)

HRTG

Heritage Insurance

$15.46

-0.19 (-1.21%)

IVAC

Intevac

$4.79

-0.05 (-1.03%)

DHX

DHI Group

$3.80

0.18 (4.97%)

HIL

Hill International

$2.69

-0.01 (-0.37%)

GHM

Graham

$20.97

0.21 (1.01%)

QRHC

Quest Resource

$2.52

(0.00%)

AVID

Avid Technology

$7.97

0.03 (0.38%)

RUBI

Rubicon Project

$5.62

0.1 (1.81%)

SDPI

Superior Drilling

$1.13

-0.005 (-0.44%)

TTGT

TechTarget

$19.90

-0.01 (-0.05%)

EBS

Emergent BioSolutions

$44.10

-0.86 (-1.91%)

BGSF

BG Staffing

$17.12

-0.01 (-0.06%)

SMID

Smith-Midland Corp

$0.00

(0.00%)

FTAI

Fortress Transportation

$15.12

0.075 (0.50%)

  • 12

    Jun

  • 12

    Jun

  • 12

    Jun

  • 13

    Jun

  • 19

    Jun

  • 20

    Jun

  • 21

    Jun

  • 10

    Jul

  • 25

    Sep

  • 13

    Nov

PCTI PCTEL
$4.63

-0.03 (-0.64%)

08/09/18
RILY
08/09/18
DOWNGRADE
Target $4.5
RILY
Neutral
PCTEL downgraded to Neutral from Buy at B. Riley FBR
B. Riley FBR analyst Mike Crawford downgraded PCTEL to Neutral and lowered his price target for the shares to $4.50 from $8.50. The analyst sees the challenges that drove the reduced fiscal 2018 guidance persisting for the remainder of the year.
08/09/18
LSCM
08/09/18
DOWNGRADE
Target $6
LSCM
Hold
PCTEL downgraded to Hold with $6 target at Lake Street
Lake Street analyst Jaeson Schmidt downgraded PCTE to Hold from Buy and lowered his price target for the shares to $6 from $9. The company's Q3 outlook and the downward adjustment to full year guidance came in well below estimates as it is seeing meaningful headwinds in both of its business segments, Schmidt tells investors in a post-earnings research note. He finds it prudent to move to the sidelines until visibility improves. B. Riley FBR also downgraded PCTEL this morning.
08/09/18
LSCM
08/09/18
DOWNGRADE
LSCM
Hold
PCTEL downgraded to Hold from Buy at Lake Street
RDWR Radware
$24.79

0.38 (1.56%)

06/25/18
NEED
06/25/18
NO CHANGE
Target $32
NEED
Buy
Radware price target raised to $32 from $26 at Needham
Needham analyst Alex Henderson raised his price target on Radware to $32 and kept his Buy rating, saying the company is gaining traction in SaaS Security with particular focus in the Cloud. Henderson notes that his confidence in Radware's position has been strengthened by his recent visit to its Israel headquarters, strengthening his perception of the company's growth prospects, competitive strength, and market share gains. The analyst adds that the management's confidence in its outlook is "stronger than at any point over the last 3-5 years".
11/29/18
BREN
11/29/18
INITIATION
Target $30
BREN
Buy
Radware initiated with a Buy at Berenberg
Berenberg analyst Alexander Frankiewicz started Radware with a Buy rating and $30 price target.
07/18/18
JEFF
07/18/18
NO CHANGE
Target $34.5
JEFF
Buy
Jefferies boosts target on favorite small-cap idea Radware to $34.50
Jefferies analyst George Notter raised his price target for Radware to $34.50 from $28 saying the company remains his favorite small-cap idea. Radware is a low-double digit top line grower that is generating operating leverage and seeing over 60% of sales coming from Recurring Revenue sources, Notter tells investors in a research note. He believes investors are still underappreciating the strength of the company's DDoS/security mitigation solutions. Notter reiterates a Buy rating on Radware shares.
UFPT UFP Technologies
$39.43

-0.12 (-0.30%)

CWCO Consolidated Water
$13.67

(0.00%)

HRTG Heritage Insurance
$15.46

-0.19 (-1.21%)

05/15/19
JMPS
05/15/19
UPGRADE
Target $19
JMPS
Outperform
JMP upgrades Heritage Insurance to Outperform after management meetings
As previously reported, JMP Securities analyst Matthew Carletti upgraded Heritage Insurance to Outperform from Market Perform, telling investors that he came away from his recent meetings with management with increased confidence in Heritage's prospects over the next 6-12 months. Underlying growth outside of Tri-County should begin to show through, recently passed legislation should help to reduce some pressures and management expressed comfort with its upcoming reinsurance renewal, Carletti stated. He set a $19 price target on Heritage shares.
05/14/19
JMPS
05/14/19
UPGRADE
JMPS
Outperform
Heritage Insurance upgraded to Outperform from Market Perform at JMP Securities
IVAC Intevac
$4.79

-0.05 (-1.03%)

07/31/18
07/31/18
UPGRADE
Target $6

Buy
Intevac upgraded to Buy on profitability expectations at Benchmark
As previously reported, Benchmark analyst Mark Miller upgraded Intevac to Buy from Hold on his view of the likelihood it can return to profitability in Q4 and 2019. He notes that Q2 earnings topped both the company's guidance and consensus, as did Q2 revenue. Miller set a $6 price target on Intevac shares.
01/03/19
BNCH
01/03/19
NO CHANGE
BNCH
Activision, Canopy Growth among Best Ideas for first half of 2019 at Benchmark
Benchmark analysts selected their Best Ideas for the first half of 2019, naming 16 stocks, including: Activision Blizzard (ATVI), BioTelemetry (BEAT), Biofrontera (BFRA), Ctrip (CTRP), Huazhu Group (HTHT), II-VI (IIVI), Intevac (IVAC), LHC Group (LHCG), Meredith (MDP), Marvell (MRVL), NeoGenomics (NEO), Pegasystems (PEGA), Silicon Labs (SLAB), Varonis (VRNS), Canopy Growth (CGC) and Waitr Holdings (WTRH).
12/20/18
12/20/18
NO CHANGE

Intevac awarded $6.9M production contract from U.S. Army
Intevac received a contract for $6.9M for the production of night vision cameras for the Apache Helicopter's Pilot Night Vision Sensor program for the U.S. Army. This contract vehicle enables the U.S. Army to procure additional units through May 2020 at pre-negotiated pricing.
07/31/18
BNCH
07/31/18
UPGRADE
BNCH
Buy
Intevac upgraded to Buy from Hold at Benchmark
DHX DHI Group
$3.80

0.18 (4.97%)

11/05/18
RILY
11/05/18
UPGRADE
Target $2.5
RILY
Buy
DHI Group upgraded to Buy from Neutral at B. Riley FBR
B. Riley FBR analyst Kara Anderson upgraded DHI Group to Buy with an unchanged price target of $2.50. After showing "stability" and margin improvement in Q3, the company's valuation "can no longer be ignored," Anderson tells investors in a research note.
03/26/19
RILY
03/26/19
INITIATION
Target $3.5
RILY
Buy
DHI Group resumed with a Buy at B. Riley FBR
B. Riley FBR analyst Marc Wiesenberger resumed coverage of DHI Group with a Buy rating and $3.50 price target.
03/15/19
RILY
03/15/19
NO CHANGE
Target $3.5
RILY
Buy
DHI Group price target raised to $3.50 from $2.50 at B. Riley FBR
B. Riley FBR analyst Kara Anderson raised her price target for DHI Group to $3.50 from $2.50 and reiterates a Buy rating on the shares.
HIL Hill International
$2.69

-0.01 (-0.37%)

07/23/18
KEYB
07/23/18
DOWNGRADE
KEYB
Sector Weight
Hill International downgraded to Sector Weight from Overweight at KeyBanc
GHM Graham
$20.97

0.21 (1.01%)

04/18/19
MAXM
04/18/19
INITIATION
Target $27
MAXM
Buy
Graham initiated with a Buy at Maxim
Maxim analyst Tate Sullivan initiated Graham with a Buy rating and a price target of $27, citing the company's "record backlog from U.S. Navy" for aircraft carrier and submarine equipment which should lead to a "meaningful rebound" in earnings. The analyst also believes that Graham may announce a 10% dividend increase in August after its first divident increase in 3 years in 2018 while anticipating the company's "less cyclical than other end markets' " orders from the U.S. Navy to continue to grow.
04/18/19
04/18/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Yelp (YELP) initiated with an Outperform at BMO Capital. 2. Ruth's Hospitality (RUTH) initiated with an Equal Weight at Stephens. 3. Conmed (CNMD) initiated with a Buy at Stifel. 4. Alcon (ALC) initiated with a Market Perform at BMO Capital. 5. Graham (GHM) initiated with a Buy at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/18/19
MAXM
04/18/19
INITIATION
MAXM
Buy
Graham initiated with a Buy at Maxim
QRHC Quest Resource
$2.52

(0.00%)

AVID Avid Technology
$7.97

0.03 (0.38%)

05/01/19
05/01/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Lyft (LYFT) initiated with a Buy at Tigress Financial. 2. Waste Management (WM) and Republic Services (RSG) were initiated with a Sector Perform at RBC Capital. 3. Identiv (INVE) initiated with an Outperform at Oppenheimer. 4. The Stars Group (TSG) initiated with an Equal Weight at Morgan Stanley. 5. Avid Technology (AVID) initiated with a Buy at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/01/19
MAXM
05/01/19
INITIATION
Target $14
MAXM
Buy
Avid Technology initiated with a Buy at Maxim
Maxim analyst Nehal Chokshi initiated Avid Technology with a Buy rating and a price target of $14, saying the company's "sustainable technology advantage" has made it a "dominant" content creation and editing leader. The analyst sees Avid Technology remaining on track to increase its recurring revenue to 70% of total thanks to its strong brand.
03/21/19
BWSF
03/21/19
DOWNGRADE
BWSF
Sell
BWS Financial downgrades Avid to Sell from Hold following recent rally
BWS Financial analyst Hamed Khorsand downgraded Avid Technology to Sell from Hold with a price target of $5. The stock has rallied post the Q4 earnings report on "euphoria free cash flow would keep growing," Khorsand tells investors in a research note. To the contrary, the analyst argues, Avid's Q4 is seasonally the peak period of the year. Khorsand believes the company continues to face challenges in a "cash hungry first half" of 2019 and recommends using the recent rally to sell the shares.
06/07/19
JEFF
06/07/19
NO CHANGE
Target $8.5
JEFF
Hold
Avid Technology price target raised to $8.50 from $6.50 at Jefferies
Jefferies analyst Samad Samana raised his price target for Avid Technology to $8.50 from $6.50 while maintaining a Hold rating on the shares. The analyst continues to see the company's fiscal 2019 guidance as achievable. The recent news that the U.S. might impose tariffs on Mexico has led to questions from investors about the potential impact, Samana tells investors in a research note. He estimates a 5% tariff level would only have a minimal impact on the overall expected savings projected by Avid Technology. The company previously guided to $10M of annualized savings as a result of its supply chain transition to a supplier in Mexico, notes Samana.
RUBI Rubicon Project
$5.62

0.1 (1.81%)

04/02/19
CHLM
04/02/19
NO CHANGE
Target $8
CHLM
Buy
Chrome changes overblown, buying opportunity for Rubicon, says Craig-Hallum
Craig-Hallum analyst Jason Kreyer believes the recent pullback in Rubicon Project (RUBI) shares creates a buying opportunity. Shares were down nearly 10% last week following rumors that Google (GOOG) could make privacy changes to its Chrome browser, he notes. The analyst does not anticipate this creating any fundamental headwinds for Rubicon Project and believes management's focus on releasing a suite of tools for publishers positions the company for further competitive gains. He reiterates a Buy rating and $8 price target on Rubicon's shares.
04/17/19
RILY
04/17/19
INITIATION
Target $9
RILY
Buy
Rubicon Project initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Lee Krowl started Rubicon Project with a Buy rating and $9 price target. The analyst sees the company as fundamentally well positioned following a multiyear restructuring and industry "shakeout."
10/12/18
CHLM
10/12/18
NO CHANGE
CHLM
Buy
Rubicon Project lawsuit settlement removes overhang, says Craig-Hallum
Rubicon Project has reached an agreement to settle a lawsuit with The Guardian, Craig-Hallum analyst Jason Kreyer tells investors in a research note. Kreyer believes the settlement removes an overhang on the stock, and notes that the financial terms of the settlement are immaterial. The analyst continues to see an improving fundamental opportunity for Rubicon Project and maintains a Buy rating.
06/26/18
CHLM
06/26/18
NO CHANGE
Target $4
CHLM
Buy
Rubicon Project to benefit from AT&T acquisition of AppNexus, says Craig-Hallum
Craig-Hallum analyst Jason Kreyer notes that AT&T (T) announced the acquisition of AppNexus, a deal rumored to be valued at $1.6B. The analyst sees this deal having a ripple effect through the ad tech landscape, particularly as it relates to the publisher's end of the spectrum. In his view, Rubicon Project (RUBI) stands to benefit substantially by the removal of an aggressive competitor, with thousands of publishers and hundreds of millions of advertising spend likely searching for a new home. Further, Kreyer now sees the integration of AppNexus under the AT&T umbrella as the number one growth catalyst for Rubicon over the next 12-18 months as a substantial volume of ad impressions likely search for a new home. He reiterates a Buy rating and $4 price target on Rubicon's shares.
SDPI Superior Drilling
$1.13

-0.005 (-0.44%)

10/18/18
IMPC
10/18/18
NO CHANGE
Target $5
IMPC
Outperform
Superior Drilling price target raised to $5 from $3 at Imperial Capital
Imperial Capital analyst Jason Wangler raised his price target for Superior Drilling Products to $5 after the company announced that its establishing a service partner in the Middle East. The agreement shows the continued focus and success of Superior Drilling's push into the Middle East for its Drill-N-Ream product, Wangler tells investors in a research note. He believes this can add "significant" revenue and EBITDA in the future alongside continued domestic market penetration for the product. The analyst keeps an Outperform rating on the shares.
09/18/18
ROTH
09/18/18
DOWNGRADE
Target $2.5
ROTH
Neutral
Superior Drilling downgraded to Neutral from Buy at Roth Capital
Roth Capital analyst John White downgraded Superior Drilling to Neutral from Buy with a $2.50 price target. In a research note to investors, White says Superior Drilling began reporting "strongly positive" financial results starting in 4Q17 and "apparently the market has taken notice," as shares are up 49% since reporting Q2 results. White says he awaits the company's Q3 operations update and earnings to update estimates and rating accordingly.
03/08/19
ROTH
03/08/19
UPGRADE
ROTH
Buy
Superior Drilling upgraded to Buy from Neutral at Roth Capital
11/28/18
IMPC
11/28/18
NO CHANGE
Target $3
IMPC
Outperform
Superior Drilling price target lowered to $3 from $5 at Imperial Capital
Imperial Capital analyst Jason Wangler lowered his price target for Superior Drilling Products to $3 after the company announced the amendment and extension of the majority of its debt obligations. The analyst, however, keeps an Outperform rating on the shares. Superior continues to improve its operational and financial capabilities, Wangler tells investors in a research note.
TTGT TechTarget
$19.90

-0.01 (-0.05%)

02/07/19
CHLM
02/07/19
NO CHANGE
Target $16
CHLM
Hold
TechTarget price target lowered to $16 from $23 at Craig-Hallum
Craig-Hallum analyst Mike Malouf lowered his price target for TechTarget to $16 from $23 as its legacy Core Online business of monetizing micro-specific websites that provide information to millions of domestic IT professionals continues to show weak results as large customers remain cautious around their marketing spend. While the analyst continues to see solid prospects for IT Deal Alert and expects that segment to be the primary secular growth driver in the coming years, the lackluster marketing spend environment is impacting that business as well. Malouf reiterates a Hold rating on the shares.
05/09/19
LSCM
05/09/19
NO CHANGE
Target $24
LSCM
Buy
TechTarget target raised to $24 after Q1 upside at Lake Street
Lake Street analyst Eric Martinuzzi raised his price target for TechTarget to $24 from $23 citing the company's Q1 upside and increased 2019 EBITDA guidance. He keeps a Buy rating on the shares.
05/09/19
CHLM
05/09/19
UPGRADE
Target $26
CHLM
Buy
TechTarget upgraded to Buy from Hold at Craig-Hallum
Craig-Hallum analyst Mike Malouf upgraded TechTarget to Buy from Hold and raised his price target for the shares to $26 from $16. The analyst sees "heightened visibility of profitable growth" following last night's results. He believes TechTarget's Core Online business is seeing "solid" results.
02/07/19
LSCM
02/07/19
NO CHANGE
Target $23
LSCM
Buy
TechTarget price target lowered to $23 from $26 at Lake Street
Lake Street analyst Eric Martinuzzi lowered his price target for TechTarget to $23 and reiterates a Buy rating on the shares following the company's Q4 results. Similar to last quarter, TechTarget says a few large customers are still finalizing budgets due to trade uncertainty, Martinuzzi tells investors in a research note. Further, while relatively small, there continues to be a negative overhang for a small number of large accounts around Europe's General Data Protection Regulation, adds the analyst. He points out TechTarget's fiscal 2019 growth is skewed towards the second half, which increases execution risk.
EBS Emergent BioSolutions
$44.10

-0.86 (-1.91%)

04/02/19
WELS
04/02/19
NO CHANGE
Target $68
WELS
Market Perform
BARDA passing on Pfenex good news for Emergent, says Wells Fargo
The decision by the Department of Health and Human Services' Biomedical Advanced Research and Development Authority not to exercise development options on Pfenex's (PFNX) anthrax program is good news for Emergent BioSolutions (EBS), Wells Fargo analyst David Maris tells investors in a research note. Emergent currently sells BioThrax, a vaccine indicated for the active immunization for the prevention of disease caused by anthrax, Maris points out. In addition, NuThrax is the company's most important pipeline product as it represents an improvement on BioThrax, says the analyst. He sees the move by BARDA on the Pfenex program as underscoring its belief in the BioThrax and NuThrax programs. Maris keeps a Market Perform rating on Emergent BioSolutions with a $68 price target. The stock in early trading is up 58c to $50.81.
05/09/19
WELS
05/09/19
NO CHANGE
Target $61
WELS
Market Perform
Emergent BioSolutions price target lowered to $61 from $68 at Wells Fargo
Wells Fargo analyst David Maris lowered his price target on Emergent BioSolutions to $61 and kept his Market Perform rating after its miss on Q1 revenue and earnings last week. The analyst also lowers his FY19 and FY20 EPS outlook by 7c and 41c to $3.01 and $3.27 respectively, reflecting the delays in its negotiations for a follow-on contact for its AMAC2000 Smallpox Vaccine and the management's expectations for its FY19 earnings to be "even more heavily back half weighted."
04/22/19
CANT
04/22/19
NO CHANGE
Target $75
CANT
Overweight
Emergent shares largely pricing in Teva approval, says Cantor Fitzgerald
The FDA on Friday granted Teva Pharmaceutical (TEVA) final approval for its generic version of Narcan, Cantor Fitzgerald analyst Brandon Folkes tells investors in a research note. The analyst views the announcement as largely anticipated following the expiration of Teva's 30- month stay last month. Shares of Emergent BioSolutions (EBS) are down 18.7% since reporting Q4 earnings, largely driven by the anticipation of a final approval of Teva's generic naloxone, says Folkes. While Friday's approval is a negative and will continue to create an overhang on Emergent shares, the recent weakness has "adequately accounted for this overhang," he contends. As such, Folkes keeps an Overweight rating on Emergent BioSolutions with a $75 price target.
06/03/19
WELS
06/03/19
NO CHANGE
Target $61
WELS
Market Perform
Size, timeline of Emergent new contract 'a clear positive,' says Wells Fargo
Wells Fargo analyst David Maris notes that Emergent BioSolutions announced that it was awarded a 10-year contract award by the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services valued at approximately $535M. The company stated that the U.S. government has never awarded a 10-year contract for Vaccinia Immune Globulin Intravenous, and the last VIGIV contract was a 1-year $26M contract that was signed in February 2018, he points out, adding the contract prior to that was a 3-year $92M contract. The analyst views the size and timeline of the newly announced VIGIV contract as a clear positive. Further, Maris continues to think the ACAM2000 follow on contracts is a "when" not an "if" and expects the shares to trade higher when this contract negotiation is completed. He reiterates a Market Perform rating and a $61 price target on the stock.
BGSF BG Staffing
$17.12

-0.01 (-0.06%)

SMID Smith-Midland Corp
$0.00

(0.00%)

FTAI Fortress Transportation
$15.12

0.075 (0.50%)

TODAY'S FREE FLY STORIES

WSC

WillScot

$14.18

-0.17 (-1.18%)

21:53
06/25/19
06/25
21:53
06/25/19
21:53
Initiation
WillScot initiated at DA Davidson »

WillScot initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYRN

Cyren

$1.60

(0.00%)

21:32
06/25/19
06/25
21:32
06/25/19
21:32
Initiation
Cyren initiated at B. Riley FBR »

Cyren initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VEC

Vectrus

$38.28

-0.12 (-0.31%)

21:32
06/25/19
06/25
21:32
06/25/19
21:32
Initiation
Vectrus initiated at B. Riley FBR »

Vectrus initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSPN

OneSpan

$13.81

-0.38 (-2.68%)

21:32
06/25/19
06/25
21:32
06/25/19
21:32
Initiation
OneSpan initiated at B. Riley FBR »

OneSpan initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMBM

Cambium Networks

$0.00

(0.00%)

21:29
06/25/19
06/25
21:29
06/25/19
21:29
Syndicate
Cambium Networks 5.8M share IPO price $12.00 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

VICI

VICI Properties

$21.80

-0.52 (-2.33%)

21:27
06/25/19
06/25
21:27
06/25/19
21:27
Syndicate
VICI Properties 100M share Secondary priced at $21.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

20:25
06/25/19
06/25
20:25
06/25/19
20:25
Conference/Events
CLSA Asian tech analysts to hold an analyst/industry conference call »

Asian Technology Analysts…

GIS

General Mills

$53.70

0.04 (0.07%)

, PAYX

Paychex

$84.76

-1.41 (-1.64%)

20:25
06/25/19
06/25
20:25
06/25/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

GIS

General Mills

$53.70

0.04 (0.07%)

PAYX

Paychex

$84.76

-1.41 (-1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 09

    Jul

  • 10

    Jul

  • 11

    Jul

BAX

Baxter

$81.71

-0.58 (-0.70%)

19:32
06/25/19
06/25
19:32
06/25/19
19:32
Initiation
Baxter initiated at KeyBanc »

Baxter initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 16

    Sep

FB

Facebook

$188.87

-3.69 (-1.92%)

19:21
06/25/19
06/25
19:21
06/25/19
19:21
Periodicals
Brazil court reduces fine for Facebook's refusal to share data, Reuters says »

A Brazilian federal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 16

    Jul

PCG

PG&E

$21.62

-0.02 (-0.09%)

19:01
06/25/19
06/25
19:01
06/25/19
19:01
Periodicals
PG&E bondholders seek control of utility's bankruptcy, SVBJ reports »

PG&E's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMI

Kinder Morgan

$20.58

-0.58 (-2.74%)

18:55
06/25/19
06/25
18:55
06/25/19
18:55
Hot Stocks
Kinder Morgan says 'very pleased' with Travis County District Court ruling »

Kinder Morgan issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$32.71

-0.47 (-1.42%)

, FDX

FedEx

$156.00

-4.88 (-3.03%)

18:37
06/25/19
06/25
18:37
06/25/19
18:37
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Micron…

MU

Micron

$32.71

-0.47 (-1.42%)

FDX

FedEx

$156.00

-4.88 (-3.03%)

AVAV

AeroVironment

$61.41

-0.52 (-0.84%)

GBT

Global Blood Therapeutics

$62.42

-0.87 (-1.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 09

    Jul

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

  • 26

    Jun

18:15
06/25/19
06/25
18:15
06/25/19
18:15
General news
Breaking General news story  »

St. Louis Federal Reserve…

CMCSA

Comcast

$42.75

-0.85 (-1.95%)

, CMCSK

Comcast

$0.00

(0.00%)

18:06
06/25/19
06/25
18:06
06/25/19
18:06
Periodicals
NBC to pull 'The Office' from Netflix in 2021, CNBC says »

Comcast's (CMCSA)…

CMCSA

Comcast

$42.75

-0.85 (-1.95%)

CMCSK

Comcast

$0.00

(0.00%)

NFLX

Netflix

$360.29

-10.72 (-2.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 17

    Jul

  • 25

    Jul

FDX

FedEx

$156.00

-4.88 (-3.03%)

18:03
06/25/19
06/25
18:03
06/25/19
18:03
Hot Stocks
FedEx says U.S. government placing burden on carriers with regulations »

Says lawsuit over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

18:01
06/25/19
06/25
18:01
06/25/19
18:01
Hot Stocks
FedEx says Huawei packages 'only peripherally' involved in U.S. lawsuit »

Says there's been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

QD

Qudian

$8.46

-0.275 (-3.15%)

18:00
06/25/19
06/25
18:00
06/25/19
18:00
Syndicate
Breaking Syndicate news story on Qudian »

Qudian files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$156.00

-4.88 (-3.03%)

, AMZN

Amazon.com

$1,879.26

-34.17 (-1.79%)

17:57
06/25/19
06/25
17:57
06/25/19
17:57
Hot Stocks
Breaking Hot Stocks news story on FedEx, Amazon.com »

FedEx says loss of Amazon…

FDX

FedEx

$156.00

-4.88 (-3.03%)

AMZN

Amazon.com

$1,879.26

-34.17 (-1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 10

    Jul

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:56
06/25/19
06/25
17:56
06/25/19
17:56
Hot Stocks
FedEx sees buyback level significantly lower in FY20 »

Says has created new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:51
06/25/19
06/25
17:51
06/25/19
17:51
Hot Stocks
FedEx says has made no pricing changes »

Says business realignment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:46
06/25/19
06/25
17:46
06/25/19
17:46
Hot Stocks
FedEx says international commercial team still poised for growth »

Says TNT Express…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:43
06/25/19
06/25
17:43
06/25/19
17:43
Hot Stocks
FedEx says global trade picture 'less than ideal' »

Says "all-in"…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:38
06/25/19
06/25
17:38
06/25/19
17:38
Hot Stocks
FedEx calls FY20 a 'transition year' »

Says FY20 a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:37
06/25/19
06/25
17:37
06/25/19
17:37
Hot Stocks
FedEx says intends to substantially grow e-commerce business »

Sees FedEx Freight will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.